Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Ocugen, Inc. Common Stock

OCGN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
OCGN Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
OCGN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
OCGN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in OCGN holdings by institutional investors

Quarterly net insider trading by OCGN's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $30,000 Jul 16, 2026 Issue: Health Issues
  • $30,000 Apr 16, 2026 Issue: Health Issues
  • $30,000 Jan 20, 2026 Issue: Health Issues
  • $30,000 Oct 19, 2025 Issue: Health Issues
  • $30,000 Jul 20, 2025 Issue: Health Issues
  • $30,000 Apr 21, 2025 Issue: Health Issues
  • $30,000 Jan 21, 2025 Issue: Health Issues
  • $30,000 Oct 19, 2024 Issue: Health Issues
  • $60,000 Jul 22, 2024 Issue: Health Issues
  • $30,000 Oct 20, 2023 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
  • $60,000 Oct 19, 2023 Issue: Health Issues
  • $30,000 Jul 20, 2023 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
  • $30,000 Jul 19, 2023 Issue: Health Issues
  • $105,000 Feb 23, 2023 Issue: Health Issues
  • $10,000 Jan 20, 2023 Issue: Health Issues
  • $105,000 Nov 16, 2022 Issue: Health Issues
  • $105,000 Aug 08, 2022 Issue: Health Issues
  • $20,000 Jul 20, 2022 Issue: Pharmacy
  • $105,000 Jun 09, 2022 Issue: Health Issues
  • $130,000 Apr 20, 2022 Issue: Pharmacy
  • $60,000 Jan 20, 2022 Issue: Health Issues
  • $130,000 Jan 20, 2022 Issue: Pharmacy
  • $60,000 Oct 21, 2021 Issue: Health Issues
  • $30,000 Oct 20, 2021 Issue: Pharmacy
  • $60,000 Jul 19, 2021 Issue: Health Issues
  • $60,000 Jul 19, 2021 Issue: Health Issues

Former government officials who have lobbied for OCGN

6 former government officials from 2 congressional offices at 3 lobbying firms have lobbied for OCGN, most recently Oct 20, 2023.

  • Tim Hutchinson
    Darin Gardner Senate Legislative Correspondent Senator Tim Hutchinson; Research AssistantSenate HELP Committee; Chief of Staff Congresswoman Kay Granger Formerly with Tim Hutchinson · THE CONAFAY GROUP, LLC · Oct 20, 2023
  • Zaida Ricker House 2017 - 2018 House LA Formerly 2017 - 2018 House LA · RIDGE POLICY GROUP · Jan 20, 2023
  • Rebeccah Wolfkiel House 2004-2010/House LD Formerly 2004-2010/House LD · RIDGE POLICY GROUP · Jan 20, 2023
  • Charles Moffat Senate Senate Committee on Banking, Housing, and Urban Affairs- HearingClerk 1/19-8/21; Assistant Clerk 8/21-12/21 Senate Intern 8/18-12/18 Formerly Senate Committee on Banking, Housing, and Urban Affairs- HearingClerk 1/19-8/21; · RIDGE POLICY GROUP · Jan 20, 2023
  • Mark Holman Other 2001 - 2002 Dep. Asst. to Pres. for Homeland Security Formerly 2001 - 2002 Dep. Asst. to Pres. for Homeland Security · RIDGE POLICY GROUP · Jan 20, 2023
  • Glenn Thompson
    Katie Brown House Legislative Assistant, Senior Legislative Assistant, Rep. Glenn Thompson 15-17; Health Policy Advisor, Legislative Aide, Scheduler, Constituent Advocate, Staff Assistant, Rep. Mike Fitzpatrick 11-15 Formerly with Glenn Thompson · FTI GOVERNMENT AFFAIRS · Jul 20, 2022

OCGN Estimated quarterly lobbying spending

OCGN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
OCGN Income Statement
OCGN Balance Sheet
OCGN Cash Flow
U.S. Patents

New OCGN patent grants

  • Patent Title: Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof Jul. 01, 2025
  • Patent Title: Method for use of a double-structured tissue implant for treatment of tissue May. 16, 2023
  • Patent Title: Cell and tissue culture container Jan. 17, 2023
  • Patent Title: Preservative free ocular compositions and methods for using the same for treating dry eye disease and other eye disorders Aug. 25, 2020
  • Patent Title: Ophthalmic compositions and methods of use Feb. 11, 2020
  • Patent Title: Methods and compositions for treating dry eye disease and other eye disorders Jan. 30, 2018
  • Patent Title: Methods and compositions for treating dry eye disease and other eye disorders Mar. 21, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to OCGN from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
OCGN News

Recent insights relating to OCGN

CNBC Recommendations

Recent picks made for OCGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OCGN

OCGN Analyst Ratings

OCGN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
OCGN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $OCGN stock a Buy, Sell, or Hold?

  • What is the price target for $OCGN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

OCGN Top Shareholders
Shareholder
Shares Held
OCGN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $OCGN stock?

  • Who owns the most shares of $OCGN stock?

  • What funds own $OCGN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

OCGN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view OCGN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About OCGN

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

  • Address Malvern, PA
  • Market Cap 339.1 million
  • Employees 116
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Ocugen, Inc. Common Stock (OCGN) Historical Stock Prices

Ocugen, Inc. Common Stock (OCGN) closed at $1.00 on September 24, 2026. Over the past year its adjusted close ranged from $0.9935 to $2.48. Daily prices go back to December 3, 2014, 2,967 trading days in all.

  • 1 month-28.57%
  • 3 months-27.01%
  • Year to date-25.93%
  • 1 year-39.02%
  • 3 years+150.00%
  • 5 years-86.72%
  • Max-91.49%
See every congressional and insider trade on the OCGN price chart

Quiver Premium charts OCGN's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 0.9965 1.02 0.9701 1.00 1.00 5,621,852
Sep 23, 2026 1.06 1.06 0.9816 1.00 1.00 12,171,356
Sep 22, 2026 1.05 1.08 1.03 1.04 1.04 5,713,352
Sep 21, 2026 1.05 1.08 1.02 1.03 1.03 4,155,607
Sep 18, 2026 1.02 1.08 1.00 1.06 1.06 14,758,161
Sep 17, 2026 1.02 1.06 1.01 1.03 1.03 3,914,512
Sep 16, 2026 0.9970 1.01 0.9700 0.9984 0.9984 9,093,641
Sep 15, 2026 1.05 1.06 0.9800 0.9935 0.9935 12,645,332
Sep 14, 2026 1.03 1.07 1.00 1.06 1.06 6,680,320
Sep 11, 2026 1.04 1.06 1.01 1.02 1.02 6,471,092
Sep 10, 2026 1.09 1.09 1.01 1.02 1.02 22,253,251
Sep 9, 2026 1.31 1.32 1.06 1.06 1.06 39,260,038
Sep 8, 2026 1.35 1.36 1.32 1.33 1.33 2,818,693
Sep 4, 2026 1.32 1.38 1.31 1.36 1.36 3,567,525
Sep 3, 2026 1.33 1.35 1.30 1.35 1.35 2,416,083
Sep 2, 2026 1.34 1.38 1.31 1.32 1.32 4,284,876
Sep 1, 2026 1.33 1.34 1.29 1.33 1.33 2,180,897
Aug 31, 2026 1.31 1.34 1.28 1.33 1.33 4,663,343
Aug 28, 2026 1.37 1.37 1.32 1.32 1.32 3,100,322
Aug 27, 2026 1.42 1.42 1.36 1.37 1.37 2,903,841
Aug 26, 2026 1.41 1.42 1.38 1.41 1.41 2,013,563
Aug 25, 2026 1.39 1.43 1.38 1.40 1.40 4,594,843
Aug 24, 2026 1.41 1.41 1.33 1.36 1.36 2,888,327
Aug 21, 2026 1.41 1.42 1.37 1.39 1.39 2,446,629
Aug 20, 2026 1.45 1.46 1.38 1.39 1.39 3,961,826
Aug 19, 2026 1.38 1.49 1.35 1.48 1.48 6,882,661
Aug 18, 2026 1.38 1.38 1.32 1.34 1.34 2,527,228
Aug 17, 2026 1.34 1.38 1.32 1.38 1.38 2,501,078
Aug 14, 2026 1.36 1.36 1.31 1.35 1.35 2,978,231
Aug 13, 2026 1.41 1.44 1.34 1.35 1.35 3,921,560
Aug 12, 2026 1.37 1.42 1.36 1.40 1.40 3,182,828
Aug 11, 2026 1.32 1.37 1.30 1.37 1.37 2,471,407
Aug 10, 2026 1.27 1.32 1.26 1.31 1.31 3,808,718
Aug 7, 2026 1.26 1.30 1.25 1.28 1.28 4,537,422
Aug 6, 2026 1.25 1.31 1.21 1.24 1.24 5,560,881
Aug 5, 2026 1.30 1.33 1.27 1.28 1.28 6,304,968
Aug 4, 2026 1.27 1.32 1.24 1.31 1.31 6,551,201
Aug 3, 2026 1.25 1.28 1.23 1.25 1.25 3,549,347
Jul 31, 2026 1.29 1.30 1.23 1.23 1.23 4,149,005
Jul 30, 2026 1.22 1.27 1.19 1.26 1.26 3,509,710
Jul 29, 2026 1.25 1.25 1.17 1.19 1.19 6,983,650
Jul 28, 2026 1.27 1.27 1.21 1.24 1.24 4,879,004
Jul 27, 2026 1.25 1.31 1.24 1.26 1.26 5,037,488
Jul 24, 2026 1.27 1.27 1.21 1.21 1.21 4,119,147
Jul 23, 2026 1.28 1.28 1.24 1.27 1.27 3,295,851
Jul 22, 2026 1.29 1.32 1.28 1.29 1.29 3,292,144
Jul 21, 2026 1.32 1.35 1.26 1.30 1.30 7,690,100
Jul 20, 2026 1.35 1.39 1.30 1.33 1.33 4,634,363
Jul 17, 2026 1.35 1.38 1.34 1.36 1.36 3,844,188
Jul 16, 2026 1.43 1.44 1.35 1.37 1.37 5,003,426
Jul 15, 2026 1.46 1.48 1.42 1.43 1.43 3,577,055
Jul 14, 2026 1.42 1.46 1.38 1.43 1.43 4,964,447
Jul 13, 2026 1.44 1.47 1.40 1.41 1.41 5,548,395
Jul 10, 2026 1.48 1.49 1.41 1.47 1.47 3,513,278
Jul 9, 2026 1.50 1.50 1.41 1.47 1.47 5,465,970
Jul 8, 2026 1.47 1.53 1.46 1.50 1.50 7,570,739
Jul 7, 2026 1.51 1.52 1.42 1.50 1.50 4,758,937
Jul 6, 2026 1.51 1.53 1.48 1.49 1.49 5,463,006
Jul 2, 2026 1.51 1.60 1.50 1.51 1.51 6,961,503
Jul 1, 2026 1.53 1.56 1.48 1.48 1.48 5,810,228
Jun 30, 2026 1.68 1.69 1.53 1.53 1.53 11,445,579
Jun 29, 2026 1.53 1.68 1.51 1.67 1.67 14,239,023
Jun 26, 2026 1.36 1.52 1.36 1.50 1.50 57,047,121
Jun 25, 2026 1.42 1.44 1.36 1.37 1.37 5,757,664
Jun 24, 2026 1.37 1.47 1.36 1.39 1.39 6,545,589
Jun 23, 2026 1.28 1.43 1.28 1.38 1.38 8,224,976
Jun 22, 2026 1.27 1.33 1.26 1.29 1.29 6,219,352
Jun 18, 2026 1.25 1.32 1.24 1.24 1.24 26,269,780
Jun 17, 2026 1.20 1.28 1.18 1.23 1.23 6,326,911
Jun 16, 2026 1.22 1.22 1.16 1.18 1.18 7,714,206
Jun 15, 2026 1.27 1.28 1.21 1.22 1.22 6,340,386
Jun 12, 2026 1.22 1.25 1.20 1.21 1.21 3,743,289
Jun 11, 2026 1.18 1.25 1.17 1.22 1.22 4,858,313
Jun 10, 2026 1.21 1.25 1.18 1.19 1.19 5,758,335
Jun 9, 2026 1.27 1.31 1.22 1.24 1.24 4,580,021
Jun 8, 2026 1.30 1.31 1.25 1.26 1.26 3,388,974
Jun 5, 2026 1.37 1.37 1.28 1.28 1.28 5,284,250
Jun 4, 2026 1.30 1.39 1.30 1.37 1.37 3,531,864
Jun 3, 2026 1.34 1.35 1.30 1.30 1.30 4,432,854
Jun 2, 2026 1.37 1.38 1.33 1.34 1.34 4,377,725
Jun 1, 2026 1.38 1.40 1.35 1.37 1.37 5,571,496
May 29, 2026 1.41 1.42 1.37 1.38 1.38 12,730,170
May 28, 2026 1.38 1.43 1.38 1.41 1.41 4,691,875
May 27, 2026 1.35 1.43 1.34 1.38 1.38 5,308,545
May 26, 2026 1.35 1.41 1.34 1.34 1.34 5,568,074
May 22, 2026 1.35 1.38 1.33 1.34 1.34 3,936,042
May 21, 2026 1.34 1.38 1.32 1.35 1.35 4,141,791
May 20, 2026 1.30 1.37 1.30 1.36 1.36 4,044,111
May 19, 2026 1.33 1.34 1.27 1.30 1.30 5,555,124
May 18, 2026 1.39 1.40 1.31 1.34 1.34 6,563,853
May 15, 2026 1.44 1.46 1.38 1.39 1.39 4,785,060
May 14, 2026 1.46 1.47 1.41 1.46 1.46 4,238,647
May 13, 2026 1.48 1.49 1.45 1.47 1.47 4,418,524
May 12, 2026 1.47 1.51 1.44 1.47 1.47 6,725,167
May 11, 2026 1.53 1.60 1.46 1.48 1.48 9,629,028
May 8, 2026 1.50 1.52 1.45 1.51 1.51 10,152,531
May 7, 2026 1.46 1.51 1.38 1.44 1.44 13,596,979
May 6, 2026 1.53 1.53 1.45 1.46 1.46 15,443,956
May 5, 2026 1.55 1.57 1.48 1.49 1.49 29,509,835
May 4, 2026 1.80 1.90 1.80 1.85 1.85 8,716,188
May 1, 2026 1.73 1.80 1.72 1.80 1.80 3,785,126
Apr 30, 2026 1.69 1.75 1.68 1.73 1.73 4,041,049
Apr 29, 2026 1.68 1.70 1.63 1.68 1.68 3,597,009
Apr 28, 2026 1.71 1.76 1.65 1.66 1.66 4,561,797
Apr 27, 2026 1.68 1.75 1.66 1.70 1.70 4,531,052
Apr 24, 2026 1.67 1.68 1.58 1.66 1.66 6,141,404
Apr 23, 2026 1.71 1.74 1.67 1.67 1.67 5,548,510
Apr 22, 2026 1.80 1.80 1.67 1.68 1.68 12,455,440
Apr 21, 2026 1.88 1.88 1.76 1.77 1.77 4,009,583
Apr 20, 2026 1.86 1.87 1.67 1.85 1.85 11,641,336
Apr 17, 2026 1.97 2.04 1.96 1.99 1.99 5,193,729
Apr 16, 2026 1.97 2.01 1.88 1.93 1.93 4,805,962
Apr 15, 2026 1.82 1.95 1.80 1.95 1.95 5,999,558
Apr 14, 2026 1.81 1.85 1.78 1.80 1.80 4,608,216
Apr 13, 2026 1.75 1.81 1.71 1.79 1.79 5,693,946
Apr 10, 2026 1.89 1.91 1.75 1.76 1.76 6,490,288
Apr 9, 2026 1.85 1.97 1.84 1.87 1.87 5,771,825
Apr 8, 2026 1.86 1.92 1.84 1.86 1.86 4,656,718
Apr 7, 2026 1.76 1.79 1.68 1.74 1.74 4,926,299
Apr 6, 2026 1.80 1.83 1.75 1.77 1.77 4,408,012
Apr 2, 2026 1.75 1.81 1.72 1.79 1.79 5,037,360
Apr 1, 2026 1.84 1.90 1.79 1.79 1.79 7,324,697
Mar 31, 2026 1.75 1.83 1.75 1.81 1.81 7,515,961
Mar 30, 2026 1.84 1.87 1.73 1.75 1.75 7,312,125
Mar 27, 2026 1.95 1.96 1.86 1.87 1.87 6,240,855
Mar 26, 2026 1.98 2.03 1.90 1.96 1.96 8,020,360
Mar 25, 2026 1.98 2.11 1.93 1.95 1.95 12,756,387
Mar 24, 2026 2.04 2.04 1.79 1.92 1.92 17,385,687
Mar 23, 2026 2.22 2.29 1.97 2.10 2.10 13,625,360
Mar 20, 2026 2.23 2.28 2.01 2.04 2.04 25,070,003
Mar 19, 2026 2.26 2.30 2.14 2.24 2.24 8,845,311
Mar 18, 2026 2.50 2.56 2.28 2.29 2.29 11,422,637
Mar 17, 2026 2.46 2.73 2.33 2.45 2.45 18,033,001
Mar 16, 2026 2.51 2.67 2.31 2.33 2.33 11,827,854
Mar 13, 2026 2.46 2.67 2.40 2.48 2.48 15,475,210
Mar 12, 2026 2.30 2.44 2.21 2.34 2.34 15,902,857
Mar 11, 2026 1.84 2.37 1.84 2.30 2.30 40,979,796
Mar 10, 2026 1.68 1.80 1.67 1.77 1.77 4,795,780
Mar 9, 2026 1.55 1.68 1.54 1.66 1.66 5,437,616
Mar 6, 2026 1.74 1.77 1.60 1.61 1.61 5,628,716
Mar 5, 2026 1.94 1.96 1.70 1.74 1.74 8,252,460
Mar 4, 2026 1.75 2.00 1.72 1.96 1.96 12,083,750
Mar 3, 2026 1.88 1.92 1.79 1.86 1.86 7,270,873
Mar 2, 2026 1.71 1.96 1.66 1.94 1.94 10,235,722
Feb 27, 2026 1.87 1.88 1.77 1.82 1.82 7,898,614
Feb 26, 2026 1.82 1.94 1.81 1.87 1.87 9,875,109
Feb 25, 2026 1.79 1.88 1.78 1.86 1.86 7,137,336
Feb 24, 2026 1.65 1.79 1.63 1.78 1.78 7,321,790
Feb 23, 2026 1.60 1.74 1.60 1.64 1.64 6,131,762
Feb 20, 2026 1.60 1.66 1.56 1.60 1.60 6,163,347
Feb 19, 2026 1.48 1.59 1.45 1.59 1.59 4,586,654
Feb 18, 2026 1.44 1.52 1.41 1.48 1.48 2,387,996
Feb 17, 2026 1.40 1.45 1.38 1.44 1.44 2,424,822
Feb 13, 2026 1.40 1.47 1.39 1.41 1.41 1,627,077
Feb 12, 2026 1.41 1.45 1.38 1.41 1.41 2,195,875
Feb 11, 2026 1.41 1.45 1.36 1.41 1.41 3,068,077
Feb 10, 2026 1.39 1.48 1.37 1.42 1.42 3,299,125
Feb 9, 2026 1.37 1.41 1.31 1.38 1.38 2,740,868
Feb 6, 2026 1.36 1.39 1.32 1.33 1.33 3,749,852
Feb 5, 2026 1.39 1.42 1.31 1.33 1.33 4,455,188
Feb 4, 2026 1.52 1.52 1.39 1.41 1.41 3,743,661
Feb 3, 2026 1.45 1.52 1.42 1.51 1.51 4,891,278
Feb 2, 2026 1.45 1.48 1.41 1.43 1.43 3,343,096
Jan 30, 2026 1.51 1.54 1.45 1.45 1.45 4,409,188
Jan 29, 2026 1.55 1.56 1.50 1.52 1.52 3,201,156
Jan 28, 2026 1.60 1.61 1.51 1.54 1.54 4,684,074
Jan 27, 2026 1.60 1.65 1.57 1.59 1.59 4,222,674
Jan 26, 2026 1.63 1.65 1.57 1.59 1.59 3,844,156
Jan 23, 2026 1.66 1.69 1.60 1.66 1.66 4,653,832
Jan 22, 2026 1.53 1.70 1.53 1.65 1.65 7,219,439
Jan 21, 2026 1.54 1.56 1.47 1.49 1.49 10,728,179
Jan 20, 2026 1.71 1.72 1.62 1.67 1.67 5,039,756
Jan 16, 2026 1.68 1.84 1.63 1.69 1.69 8,198,808
Jan 15, 2026 1.85 1.86 1.58 1.62 1.62 14,300,108
Jan 14, 2026 1.94 1.96 1.85 1.88 1.88 7,118,462
Jan 13, 2026 1.80 1.95 1.66 1.91 1.91 15,597,901
Jan 12, 2026 1.55 1.79 1.54 1.78 1.78 10,184,234
Jan 9, 2026 1.50 1.55 1.48 1.50 1.50 2,891,281
Jan 8, 2026 1.55 1.57 1.49 1.49 1.49 3,775,794
Jan 7, 2026 1.54 1.65 1.54 1.59 1.59 4,632,794
Jan 6, 2026 1.46 1.58 1.45 1.54 1.54 6,015,877
Jan 5, 2026 1.40 1.46 1.32 1.45 1.45 5,007,161
Jan 2, 2026 1.36 1.39 1.33 1.38 1.38 2,573,680
Dec 31, 2025 1.38 1.40 1.34 1.35 1.35 2,578,428
Dec 30, 2025 1.49 1.50 1.37 1.37 1.37 3,854,109
Dec 29, 2025 1.40 1.53 1.39 1.48 1.48 5,146,439
Dec 26, 2025 1.43 1.44 1.34 1.41 1.41 2,297,808
Dec 24, 2025 1.43 1.47 1.41 1.44 1.44 1,342,546
Dec 23, 2025 1.47 1.48 1.40 1.40 1.40 2,810,076
Dec 22, 2025 1.38 1.51 1.36 1.48 1.48 4,194,103
Dec 19, 2025 1.45 1.47 1.38 1.40 1.40 7,709,424
Dec 18, 2025 1.46 1.58 1.43 1.44 1.44 4,725,281
Dec 17, 2025 1.49 1.51 1.38 1.41 1.41 6,374,631
Dec 16, 2025 1.38 1.50 1.35 1.48 1.48 4,050,260
Dec 15, 2025 1.42 1.48 1.37 1.38 1.38 5,104,527
Dec 12, 2025 1.31 1.39 1.30 1.36 1.36 4,048,237
Dec 11, 2025 1.21 1.32 1.21 1.30 1.30 4,023,610
Dec 10, 2025 1.21 1.25 1.19 1.23 1.23 3,177,314
Dec 9, 2025 1.20 1.22 1.19 1.21 1.21 2,597,847
Dec 8, 2025 1.23 1.25 1.18 1.20 1.20 2,693,234
Dec 5, 2025 1.24 1.26 1.22 1.22 1.22 2,361,049
Dec 4, 2025 1.21 1.25 1.20 1.24 1.24 3,279,432
Dec 3, 2025 1.16 1.21 1.14 1.21 1.21 4,616,584
Dec 2, 2025 1.19 1.20 1.16 1.16 1.16 3,016,482
Dec 1, 2025 1.25 1.25 1.18 1.18 1.18 3,198,721
Nov 28, 2025 1.21 1.26 1.20 1.24 1.24 2,701,335
Nov 26, 2025 1.19 1.20 1.16 1.18 1.18 3,103,488
Nov 25, 2025 1.21 1.21 1.14 1.17 1.17 1,854,830
Nov 24, 2025 1.17 1.22 1.17 1.19 1.19 2,534,855
Nov 21, 2025 1.11 1.17 1.09 1.16 1.16 2,366,929
Nov 20, 2025 1.17 1.21 1.09 1.11 1.11 3,656,854
Nov 19, 2025 1.14 1.20 1.11 1.14 1.14 2,260,172
Nov 18, 2025 1.16 1.19 1.12 1.15 1.15 3,446,336
Nov 17, 2025 1.21 1.27 1.15 1.16 1.16 4,408,115
Nov 14, 2025 1.17 1.24 1.17 1.19 1.19 3,110,598
Nov 13, 2025 1.33 1.33 1.20 1.24 1.24 4,439,967
Nov 12, 2025 1.34 1.35 1.31 1.34 1.34 2,066,247
Nov 11, 2025 1.32 1.35 1.30 1.33 1.33 2,280,161
Nov 10, 2025 1.40 1.42 1.30 1.35 1.35 4,034,315
Nov 7, 2025 1.35 1.38 1.25 1.36 1.36 6,115,625
Nov 6, 2025 1.40 1.43 1.35 1.38 1.38 3,377,680
Nov 5, 2025 1.49 1.49 1.32 1.41 1.41 5,595,225
Nov 4, 2025 1.50 1.53 1.42 1.43 1.43 3,463,484
Nov 3, 2025 1.58 1.62 1.50 1.54 1.54 3,541,854
Oct 31, 2025 1.50 1.58 1.49 1.56 1.56 2,889,606
Oct 30, 2025 1.50 1.53 1.47 1.48 1.48 2,192,628
Oct 29, 2025 1.51 1.55 1.49 1.50 1.50 2,119,658
Oct 28, 2025 1.57 1.58 1.51 1.52 1.52 2,306,078
Oct 27, 2025 1.62 1.65 1.55 1.56 1.56 3,123,595
Oct 24, 2025 1.54 1.62 1.52 1.61 1.61 3,633,884
Oct 23, 2025 1.54 1.55 1.51 1.53 1.53 2,249,433
Oct 22, 2025 1.53 1.55 1.47 1.51 1.51 4,449,954
Oct 21, 2025 1.60 1.61 1.53 1.57 1.57 3,007,554
Oct 20, 2025 1.63 1.65 1.59 1.62 1.62 2,546,246
Oct 17, 2025 1.59 1.63 1.53 1.60 1.60 4,295,399
Oct 16, 2025 1.72 1.83 1.59 1.61 1.61 6,807,365
Oct 15, 2025 1.65 1.72 1.62 1.67 1.67 3,809,708
Oct 14, 2025 1.57 1.68 1.51 1.63 1.63 6,781,666
Oct 13, 2025 1.71 1.72 1.52 1.60 1.60 10,359,010
Oct 10, 2025 1.82 1.84 1.66 1.71 1.71 8,817,853
Oct 9, 2025 1.80 1.87 1.79 1.83 1.83 5,150,290
Oct 8, 2025 1.79 1.88 1.76 1.79 1.79 7,385,210
Oct 7, 2025 1.83 1.85 1.73 1.76 1.76 6,324,199
Oct 6, 2025 1.80 1.83 1.73 1.82 1.82 8,418,779
Oct 3, 2025 1.80 1.90 1.75 1.77 1.77 12,148,810
Oct 2, 2025 1.70 1.77 1.65 1.77 1.77 7,900,618
Oct 1, 2025 1.64 1.75 1.62 1.68 1.68 8,001,512
Sep 30, 2025 1.51 1.63 1.45 1.63 1.63 7,296,882
Sep 29, 2025 1.46 1.59 1.45 1.45 1.45 5,492,681
Sep 26, 2025 1.52 1.57 1.41 1.46 1.46 6,191,348
Sep 25, 2025 1.61 1.62 1.41 1.52 1.52 11,615,249
Sep 24, 2025 1.67 1.78 1.61 1.64 1.64 13,415,517

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Ocugen, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at OCGN, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation